Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure

Milton Packer

doi:10.1016/j.jchf.2019.05.013

JACC: Heart Failure

September 2019 DOI: 10.1016/j.jchf.2019.05.013

PDF Article

Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure

Milton Packer

This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article.

Author + information

DOI:

https://doi.org/10.1016/j.jchf.2019.05.013

Published By:

JACC: Heart Failure

Print ISSN:

2213-1779

Online ISSN:

2213-1787

History:

Received May 20, 2019
Revision received May 24, 2019
Accepted May 24, 2019
Published online September 11, 2019.

Article Versions

You are currently viewing a previous version of this article (September 11, 2019 - 11:00).
View the most recent version of this article.

2019 American College of Cardiology Foundation

Author Information

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.